Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Disease Progression × Breast × Clear all

Status

Sponsor Class

OTHER 8 INDUSTRY 4 NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 4 Plasma cell 2 Sarcoma 1 Gynecologic 1 Breast 1

Conditions

Breast Neoplasms 451 Breast Neoplasms, Male 72 Ovarian Neoplasms 44 Triple Negative Breast Neoplasms 40 Colonic Neoplasms 35 Neoplasms 34 Prostatic Neoplasms 33 Lung Neoplasms 33 Neoplasm Metastasis 30 Carcinoma, Non-Small-Cell Lung 29 Melanoma 28 Pancreatic Neoplasms 25 Stomach Neoplasms 21 Endometrial Neoplasms 21 Colorectal Neoplasms 21 Carcinoma, Renal Cell 21 Carcinoma, Ovarian Epithelial 21 Carcinoma, Intraductal, Noninfiltrating 18 Brain Neoplasms 18 Inflammatory Breast Neoplasms 17 Breast Carcinoma In Situ 17 Rectal Neoplasms 16 Lymphoma, Non-Hodgkin 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 14 Lymphoma, T-Cell, Cutaneous 14 Leukemia, Lymphocytic, Chronic, B-Cell 14 Urinary Bladder Neoplasms 13 Lymphoma, Large B-Cell, Diffuse 13 Lymphoma, Follicular 13 Kidney Neoplasms 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00339248 2009-03-13

Markers for Breast Cancer

National Institutes of Health Clinical Center (CC)

Breast Neoplasms, Hyperplasia, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡